Company / Current Assets per Share
LENZ Therapeutics, Inc. Current Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$10.95
FY2025
5-year range
$5.02 / $34.32
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
#70 of 210
Health Care
What the data says
At $10.95, LENZ Therapeutics, Inc.'s current assets per share ranks #70 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 6 years, ranging from $5.02 in FY2022 to $34.32 in FY2023.
Based on SEC 10-K filings.
10.95 in FY2025 with a 5-year CAGR of +3.5%.
Declined from $34.32 to $10.95 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +29.7%
- 5-Year CAGR
- +3.5%
- 10-Year CAGR
- -
Sector benchmark
#70 of 210 in Health CareTop 33% of 210This company $10.95 Sector average $170.65
▼
-93.6% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 10.0% year-over-year.
- Ranks #70 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2023.
- Lowest current assets per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.95 | +10.0% |
| FY2024 | $9.96 | -71.0% |
| FY2023 | $34.32 | +584.0% |
| FY2022 | $5.02 | -62.0% |
| FY2021 | $13.20 | +42.9% |
| FY2020 | $9.24 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026